LH LabCorp Earnings per share growth in current year

Official company branding of Labcorp Holdings Inc. (LH)

The year-over-year growth rate of net income per share demonstrates the profit dynamics of Labcorp Holdings Inc. (LH), where 12.60 serves as the final level marker. Labcorp Holdings Inc. (LH) maintains a dominant position in the laboratory segment, displacing local players through its advanced logistics. The strategy is based on partnerships with global pharma behemoths and the implementation of AI solutions in bioinformatics to optimize clinical trials.

Labcorp Holdings (LH) Earnings growth in current year: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company LabCorp (LH)

- current quotes and average value forecast:
Market Chart LabCorp|LH - Price Target Chart
- market capitalization data:
Market Value Labcorp|LH - Enterprise Value
- book capitalization indicators:
Book Value per Share Labcorp|LH - Book Capitalization|Market Value to Book Value Ratio labcorp.com|LH - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Labcorp Holdings Inc.|LH - Long-Term Debt to Equity|Current Liabilities to Capital Labcorp Holdings|LH - Company Debts|Debt to Net Assets Ratio Labcorp Holdings|LH - Company Long-Term Debt|Current Liabilities Labcorp|Intermediate Coverage Ratio labcorp.com
- earnings and market multiples details:
LH - Net Profit|Expected Net Income Labcorp Holdings Inc.|LH - Price to Earnings Ratio|Projected Price to Earnings Ratio labcorp.com|LH - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Labcorp|LH - Operating profit EBITDA|Earnings per share for the last 12 months Labcorp|LH - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months labcorp.com|LH - Earnings per share growth in current year|Projected earnings per share growth rate for next year Labcorp Holdings Inc.
- sales volume and revenue information:
LH - Revenue and Sales Volume|Company Sales Forecast LabCorp|LH - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Labcorp Holdings Inc.
Basic company analysis:LabCorp (LH)
Core merchandise of Laboratory Corporation of America

Labcorp Holdings Inc. (LH) leverages its authority in clinical diagnostics to drive financial stability through earnings per share (EPS) dynamics. This indicator measures the net income growth rate relative to the previous year, revealing the efficiency of monetizing scientific expertise and any deviations from sector averages. Analyzing the final annual EPS growth figure allows for the timely detection of hidden imbalances in the business valuation.

Main competitors

IQV: Net earnings per one share growth for the current year|Net earnings per share growth this year MEDP|ICLR (ICON plc) - Net earnings per one share growth for the current year|Earnings growth in current year CRL|EVO - Earnings per share growth rate in current year|Earnings growth in current year FTRE (Fortrea)|Lifecore - Earnings per share growth in current year|OABI - Earnings per share growth in current year|NOTV (inotivco.com) - Earnings per share growth this year|CDMO: Earnings growth in current year|CTLT: Net earnings per one share growth for the current year|Earnings per share growth in current year NightHawk Biosciences